Raia Drogasil (BOVESPA:RADL3) - Prezzo delle azioni, notizie e analisi

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

RADL3 Panoramica delle azioni

Raia Drogasil S.A. si occupa della vendita al dettaglio di farmaci, profumeria, prodotti per la cura e la bellezza della persona, cosmetici, dermocosmetici e specialità medicinali in Brasile.

Informazioni sull'azienda

RADL3 analisi fondamentale
Punteggio fiocco di neve
Valutazione	0/6
Crescita futura	5/6
Prestazioni passate	2/6
Salute finanziaria	4/6
Dividendi	0/6

Premi

Si prevede che gli utili cresceranno del 24.51% all'anno

Gli utili sono cresciuti del 13.1% all'anno negli ultimi 5 anni

Analisi del rischio

Ha un alto livello di debito

Raia Drogasil S.A. Concorrenti

Empreendimentos Pague Menos

BOVESPA:PGMN3

R$1.9b

Dimed Distribuidora de Medicamentos

BOVESPA:PNVL3

R$1.7b

Grupo Mateus

BOVESPA:GMAT3

R$17.5b

d1000 Varejo Farma Participações

BOVESPA:DMVF3

R$371.4m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Raia Drogasil
Prezzi storici delle azioni
Prezzo attuale dell'azione	R$28.28
Massimo di 52 settimane	R$30.40
Minimo di 52 settimane	R$24.30
Beta	0.33
1Variazione di 1 mese	9.74%
Variazione a 3 mesi	3.97%
Variazione di 1 anno	4.12%
3Variazione a 3 anni	14.00%
Variazione a 5 anni	64.68%
Variazione dall'IPO	4,204.09%

Notizie e aggiornamenti recenti

Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Aug 10

With Raia Drogasil S.A. (BVMF:RADL3) It Looks Like You'll Get What You Pay For

Jul 13

Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly

Apr 08

Recent updates

Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Aug 10

Raia Drogasil S.A.'s (BVMF:RADL3) Earnings Haven't Escaped The Attention Of Investors

Dec 29

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

Dec 12

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

Nov 27

Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Stalled

Oct 27

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

Sep 07

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

Aug 19

Here's What To Make Of Raia Drogasil's (BVMF:RADL3) Decelerating Rates Of Return

Jul 18

Is Raia Drogasil (BVMF:RADL3) Using Too Much Debt?

Jun 03

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

May 13

Returns At Raia Drogasil (BVMF:RADL3) Appear To Be Weighed Down

Apr 10

The Raia Drogasil S.A. (BVMF:RADL3) Yearly Results Are Out And Analysts Have Published New Forecasts

Mar 10

Is Raia Drogasil (BVMF:RADL3) A Risky Investment?

Feb 27

Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Hit The Brakes

Jan 07

Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors

Dec 07

Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly

Nov 22

Raia Drogasil (BVMF:RADL3) Could Be Struggling To Allocate Capital

Sep 08

Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors

Aug 24

Is Raia Drogasil (BVMF:RADL3) A Risky Investment?

Aug 09

There Are Reasons To Feel Uneasy About Raia Drogasil's (BVMF:RADL3) Returns On Capital

Jun 09

With EPS Growth And More, Raia Drogasil (BVMF:RADL3) Is Interesting

May 25

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

May 10

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

Feb 24

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

Feb 09

Some Investors May Be Worried About Raia Drogasil's (BVMF:RADL3) Returns On Capital

Dec 07

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

Nov 19

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

Nov 04

Returns On Capital At Raia Drogasil (BVMF:RADL3) Paint A Concerning Picture

Sep 01

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

Aug 17

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

Jul 28

Raia Drogasil (BVMF:RADL3) Will Will Want To Turn Around Its Return Trends

May 10

We Think Raia Drogasil (BVMF:RADL3) Can Stay On Top Of Its Debt

Mar 10

Do Institutions Own Raia Drogasil S.A. (BVMF:RADL3) Shares?

Feb 16

Is Raia Drogasil S.A.'s (BVMF:RADL3) Recent Performance Tethered To Its Attractive Financial Prospects?

Jan 29

You Have To Love Raia Drogasil S.A.'s (BVMF:RADL3) Dividend

Jan 11

Did Business Growth Power Raia Drogasil's (BVMF:RADL3) Share Price Gain of 253%?

Dec 24

Is Raia Drogasil (BVMF:RADL3) A Risky Investment?

Dec 03

Raia Drogasil (BVMF:RADL3) Has A Pretty Healthy Balance Sheet

Aug 25

Should We Be Excited About The Trends Of Returns At Raia Drogasil (BVMF:RADL3)?

Aug 12

What Kind Of Shareholders Hold The Majority In Raia Drogasil S.A.'s (BVMF:RADL3) Shares?

Aug 12

What You Can Learn From Raia Drogasil S.A.'s (BVMF:RADL3) P/E

Jul 30

Raia Drogasil (BVMF:RADL3) Is Growing Earnings But Are They A Good Guide?

Jul 17

Is Raia Drogasil S.A.'s(BVMF:RADL3) Recent Stock Performance Tethered To Its Strong Fundamentals?

Jul 04

Rendimenti per gli azionisti

	RADL3	BR Consumer Retailing	BR Mercato
7D	-5.7%	-1.0%	2.5%
1Y	4.1%	-8.9%	10.5%

Ritorno vs Industria: RADL3 ha superato il BR Consumer Retailing che ha restituito -8.9 % nell'ultimo anno.

Rendimento vs Mercato: RADL3 ha avuto una performance inferiore al mercato BR che ha registrato un rendimento 10.5 % nell'ultimo anno.

Volatilità dei prezzi

Is RADL3's price volatile compared to industry and market?
RADL3 volatility
RADL3 Average Weekly Movement	3.8%
Consumer Retailing Industry Average Movement	5.0%
Market Average Movement	4.6%
10% most volatile stocks in BR Market	9.3%
10% least volatile stocks in BR Market	2.4%

Prezzo delle azioni stabile: RADL3 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 4% ) di RADL3 è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1905	59,341	Marcílio Pousada	rdsaude.com.br

Raia Drogasil S.A. si occupa della vendita al dettaglio di farmaci, profumeria, prodotti per la cura e la bellezza della persona, cosmetici, dermocosmetici e specialità medicinali in Brasile. Vende i suoi prodotti attraverso negozi, televendite e call center negli Stati di San Paolo, Tocantins e Pernambuco. L'azienda è stata fondata nel 1905 e ha sede a San Paolo, in Brasile.

Raia Drogasil S.A. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Raia Drogasil con la sua capitalizzazione di mercato?
RADL3 statistiche fondamentali
Capitalizzazione di mercato	R$49.86b
Guadagni(TTM)	R$1.04b
Ricavi(TTM)	R$36.39b

46.7x

Rapporto P/E

1.3x

Rapporto P/S

RADL3 è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
RADL3 Conto economico (TTM)
Ricavi	R$36.39b
Costo del fatturato	R$25.52b
Profitto lordo	R$10.87b
Altre spese	R$9.83b
Guadagni	R$1.04b

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

Nov 05, 2024

Utile per azione (EPS)	0.61
Margine lordo	29.86%
Margine di profitto netto	2.86%
Rapporto debito/patrimonio netto	55.2%

Come si è comportato RADL3 nel lungo periodo?

Vedi performance storica e confronto

Dividendi

0.7%

Rendimento attuale del dividendo

17%

Rapporto di remunerazione

RADL3 Panoramica delle azioni

Premi

Analisi del rischio

Raia Drogasil S.A. Concorrenti

BOVESPA:PGMN3

R$1.9b

BOVESPA:PNVL3

R$1.7b

BOVESPA:GMAT3

R$17.5b

BOVESPA:DMVF3

R$371.4m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

With Raia Drogasil S.A. (BVMF:RADL3) It Looks Like You'll Get What You Pay For

Now 20% overvalued

Upcoming dividend of R$0.049 per share

Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly

Recent updates

Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

With Raia Drogasil S.A. (BVMF:RADL3) It Looks Like You'll Get What You Pay For

Now 20% overvalued

Upcoming dividend of R$0.049 per share

Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly

Does Raia Drogasil (BVMF:RADL3) Deserve A Spot On Your Watchlist?

Full year 2023 earnings released

Investors Met With Slowing Returns on Capital At Raia Drogasil (BVMF:RADL3)

Raia Drogasil S.A., Annual General Meeting, Apr 17, 2024

Raia Drogasil S.A.'s (BVMF:RADL3) Earnings Haven't Escaped The Attention Of Investors

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Stalled

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

Raia Drogasil S.A. to Report Q3, 2023 Results on Oct 31, 2023

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

Second quarter 2023 earnings: Revenues exceed analyst expectations

Here's What To Make Of Raia Drogasil's (BVMF:RADL3) Decelerating Rates Of Return

Is Raia Drogasil (BVMF:RADL3) Using Too Much Debt?

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of R$0.048 per share at 0.9% yield

Returns At Raia Drogasil (BVMF:RADL3) Appear To Be Weighed Down

The Raia Drogasil S.A. (BVMF:RADL3) Yearly Results Are Out And Analysts Have Published New Forecasts

Full year 2022 earnings: EPS exceeds analyst expectations

Is Raia Drogasil (BVMF:RADL3) A Risky Investment?

Raia Drogasil S.A. to Report Q4, 2022 Results on Mar 07, 2023

Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Hit The Brakes

Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors

Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly

Less than half of directors are independent

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Raia Drogasil S.A. to Report Q3, 2022 Results on Oct 31, 2022

Raia Drogasil (BVMF:RADL3) Could Be Struggling To Allocate Capital

Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors

Is Raia Drogasil (BVMF:RADL3) A Risky Investment?

Second quarter 2022 earnings: Revenues miss analyst expectations

Raia Drogasil S.A. to Report Q2, 2022 Results on Jul 29, 2022

There Are Reasons To Feel Uneasy About Raia Drogasil's (BVMF:RADL3) Returns On Capital

With EPS Growth And More, Raia Drogasil (BVMF:RADL3) Is Interesting

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Raia Drogasil S.A. to Report Q1, 2022 Results on May 03, 2022

Full year 2021 earnings: EPS misses analyst expectations

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

Raia Drogasil S.A. to Report Q4, 2021 Results on Feb 22, 2022

Some Investors May Be Worried About Raia Drogasil's (BVMF:RADL3) Returns On Capital

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

Third quarter 2021 earnings released

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

Returns On Capital At Raia Drogasil (BVMF:RADL3) Paint A Concerning Picture

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

Second quarter 2021 earnings released

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

First quarter 2021 earnings released

Raia Drogasil (BVMF:RADL3) Will Will Want To Turn Around Its Return Trends